BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 37103072)

  • 21. Prognostic significance of ALCAM (CD166/MEMD) expression in cutaneous melanoma patients.
    Donizy P; Zietek M; Halon A; Leskiewicz M; Kozyra C; Matkowski R
    Diagn Pathol; 2015 Jul; 10():86. PubMed ID: 26134500
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Attenuation of melanoma invasion by a secreted variant of activated leukocyte cell adhesion molecule.
    van Kilsdonk JW; Wilting RH; Bergers M; van Muijen GN; Schalkwijk J; van Kempen LC; Swart GW
    Cancer Res; 2008 May; 68(10):3671-9. PubMed ID: 18483249
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Shed urinary ALCAM is an independent prognostic biomarker of three-year overall survival after cystectomy in patients with bladder cancer.
    Arnold Egloff SA; Du L; Loomans HA; Starchenko A; Su PF; Ketova T; Knoll PB; Wang J; Haddad AQ; Fadare O; Cates JM; Lotan Y; Shyr Y; Clark PE; Zijlstra A
    Oncotarget; 2017 Jan; 8(1):722-741. PubMed ID: 27894096
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Activated leukocyte cell adhesion molecule (ALCAM) is a marker of recurrence and promotes cell migration, invasion, and metastasis in early-stage endometrioid endometrial cancer.
    Devis L; Moiola CP; Masia N; Martinez-Garcia E; Santacana M; Stirbat TV; Brochard-Wyart F; García Á; Alameda F; Cabrera S; Palacios J; Moreno-Bueno G; Abal M; Thomas W; Dufour S; Matias-Guiu X; Santamaria A; Reventos J; Gil-Moreno A; Colas E
    J Pathol; 2017 Mar; 241(4):475-487. PubMed ID: 27873306
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Predictive impact of activated leukocyte cell adhesion molecule (ALCAM/CD166) in breast cancer.
    Ihnen M; Müller V; Wirtz RM; Schröder C; Krenkel S; Witzel I; Lisboa BW; Jänicke F; Milde-Langosch K
    Breast Cancer Res Treat; 2008 Dec; 112(3):419-27. PubMed ID: 18172759
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Increased expression of ALCAM/CD166 in pancreatic cancer is an independent prognostic marker for poor survival and early tumour relapse.
    Kahlert C; Weber H; Mogler C; Bergmann F; Schirmacher P; Kenngott HG; Matterne U; Mollberg N; Rahbari NN; Hinz U; Koch M; Aigner M; Weitz J
    Br J Cancer; 2009 Aug; 101(3):457-64. PubMed ID: 19603023
    [TBL] [Abstract][Full Text] [Related]  

  • 27. ALCAM/CD166: A pleiotropic mediator of cell adhesion, stemness and cancer progression.
    Ferragut F; Vachetta VS; Troncoso MF; Rabinovich GA; Elola MT
    Cytokine Growth Factor Rev; 2021 Oct; 61():27-37. PubMed ID: 34272152
    [TBL] [Abstract][Full Text] [Related]  

  • 28. ALCAM/CD166 is overexpressed in colorectal carcinoma and correlates with shortened patient survival.
    Weichert W; Knösel T; Bellach J; Dietel M; Kristiansen G
    J Clin Pathol; 2004 Nov; 57(11):1160-4. PubMed ID: 15509676
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression and regulation of activated leukocyte cell adhesion molecule in human retinal vascular endothelial cells.
    Smith JR; Chipps TJ; Ilias H; Pan Y; Appukuttan B
    Exp Eye Res; 2012 Nov; 104():89-93. PubMed ID: 22940369
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Activated leukocyte cell adhesion molecule regulates the interaction between pancreatic cancer cells and stellate cells.
    Zhang WW; Zhan SH; Geng CX; Sun X; Erkan M; Kleeff J; Xie XJ
    Mol Med Rep; 2016 Oct; 14(4):3627-33. PubMed ID: 27573419
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Modulation of activated leukocyte cell adhesion molecule-mediated invasion triggers an innate immune gene response in melanoma.
    van Kilsdonk JW; Takahashi N; Weidle U; Burtscher H; Jarry J; Daha MR; Swart GW; van Kempen LC
    J Invest Dermatol; 2012 May; 132(5):1462-70. PubMed ID: 22318386
    [TBL] [Abstract][Full Text] [Related]  

  • 32. KRAS mutation associated with CD44/CD166 immunoexpression as predictors of worse outcome in metastatic colon cancer.
    Ribeiro KB; da Silva Zanetti J; Ribeiro-Silva A; Rapatoni L; de Oliveira HF; da Cunha Tirapelli DP; Garcia SB; Feres O; da Rocha JJ; Peria FM
    Cancer Biomark; 2016 Mar; 16(4):513-21. PubMed ID: 27062566
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Activated leukocyte cell adhesion molecule expression and shedding in thyroid tumors.
    Miccichè F; Da Riva L; Fabbi M; Pilotti S; Mondellini P; Ferrini S; Canevari S; Pierotti MA; Bongarzone I
    PLoS One; 2011 Feb; 6(2):e17141. PubMed ID: 21364949
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic Significance of Activated Leukocyte Cell Adhesion Molecule (ALCAM) in Association with Promoter Methylation of the ALCAM Gene in Breast Cancer.
    Jeong YJ; Oh HK; Park SH; Bong JG
    Molecules; 2018 Jan; 23(1):. PubMed ID: 29315254
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Subcellular localization of activated leukocyte cell adhesion molecule is a molecular predictor of survival in ovarian carcinoma patients.
    Mezzanzanica D; Fabbi M; Bagnoli M; Staurengo S; Losa M; Balladore E; Alberti P; Lusa L; Ditto A; Ferrini S; Pierotti MA; Barbareschi M; Pilotti S; Canevari S
    Clin Cancer Res; 2008 Mar; 14(6):1726-33. PubMed ID: 18347173
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Different subcellular localization of ALCAM molecules in neuroblastoma: Association with relapse.
    Corrias MV; Gambini C; Gregorio A; Croce M; Barisione G; Cossu C; Rossello A; Ferrini S; Fabbi M
    Cell Oncol; 2010; 32(1-2):77-86. PubMed ID: 20208136
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A Novel Regulatory Role of Activated Leukocyte Cell-Adhesion Molecule in the Pathogenesis of Pulmonary Fibrosis.
    Kim MN; Hong JY; Kim EG; Lee JW; Lee SY; Kim KW; Shim HS; Lee CG; Elias JA; Lee YJ; Sohn MH
    Am J Respir Cell Mol Biol; 2022 Apr; 66(4):415-427. PubMed ID: 35073245
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Activated leukocyte cell adhesion molecule/CD166, a marker of tumor progression in primary malignant melanoma of the skin.
    van Kempen LC; van den Oord JJ; van Muijen GN; Weidle UH; Bloemers HP; Swart GW
    Am J Pathol; 2000 Mar; 156(3):769-74. PubMed ID: 10702391
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Molecular basis for the homophilic activated leukocyte cell adhesion molecule (ALCAM)-ALCAM interaction.
    van Kempen LC; Nelissen JM; Degen WG; Torensma R; Weidle UH; Bloemers HP; Figdor CG; Swart GW
    J Biol Chem; 2001 Jul; 276(28):25783-90. PubMed ID: 11306570
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Activated leukocyte cell adhesion molecule expression predicts lymph node metastasis in oral squamous cell carcinoma.
    van den Brand M; Takes RP; Blokpoel-deRuyter M; Slootweg PJ; van Kempen LC
    Oral Oncol; 2010 May; 46(5):393-8. PubMed ID: 20371201
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.